P
51.26
0.28 (0.55%)
| 前收盘价格 | 50.98 |
| 收盘价格 | 49.47 |
| 成交量 | 705,647 |
| 平均成交量 (3个月) | 1,221,146 |
| 市值 | 4,062,713,600 |
| 市盈率 (P/E TTM) | 7.87 |
| 预期市盈率 (P/E Forward) | 6.37 |
| 价格/销量 (P/S) | 2.29 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | 33.56% |
| 营业利益率 (TTM) | 82.43% |
| 稀释每股收益 (EPS TTM) | 6.51 |
| 季度收入增长率 (YOY) | 459.70% |
| 流动比率 (MRQ) | 3.89 |
| 营业现金流 (OCF TTM) | 691.65 M |
| 杠杆自由现金流 (LFCF TTM) | 526.00 M |
| 资产报酬率 (ROA TTM) | 24.42% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | PTC Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.1
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -1.5 |
| 技术平均移动指标 | -3.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.13 |
|
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 2.42% |
| 机构持股比例 | 101.06% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 112.00 (Cantor Fitzgerald, 118.49%) | 购买 |
| 中 | 66.50 (29.73%) | |
| 低 | 40.00 (Citigroup, -21.97%) | 保留 |
| 平均值 | 65.88 (28.52%) | |
| 总计 | 6 购买, 2 保留 | |
| 平均价格@调整类型 | 42.30 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 27 May 2025 | 74.00 (44.36%) | 购买 | 47.86 |
| B of A Securities | 09 May 2025 | 68.00 (32.66%) | 购买 | 44.23 |
| Barclays | 08 May 2025 | 42.00 (-18.06%) | 保留 | 42.51 |
| Baird | 07 May 2025 | 66.00 (28.76%) | 购买 | 40.76 |
| Cantor Fitzgerald | 07 May 2025 | 112.00 (118.49%) | 购买 | 40.76 |
| Citigroup | 07 May 2025 | 40.00 (-21.97%) | 保留 | 40.76 |
| JP Morgan | 07 May 2025 | 67.00 (30.71%) | 购买 | 40.76 |
| 31 Mar 2025 | 75.00 (46.31%) | 购买 | 50.96 | |
| RBC Capital | 07 May 2025 | 58.00 (13.15%) | 购买 | 40.76 |
| 22 Apr 2025 | 65.00 (26.80%) | 购买 | 48.19 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合